Opinion|Videos|May 26, 2026

Understanding OFF Time in Parkinson’s Disease

Parkinson’s meds start wearing off; a patient and caregiver reveal how stress, digestion, and honest doctor talks improve symptom control.

This episode, titled ‘Understanding OFF Time in Parkinson’s Disease,’ features panelists examining how OFF time is defined and experienced from both patient and clinician perspectives. The expert neurologist explores the clinical definition of OFF time as periods when medication benefit diminishes or fails, leading to the reemergence of symptoms. The discussion also outlines the different types of OFF episodes, including morning OFF, wearing OFF, delayed ON, dose failures, and sudden OFF, emphasizing how these patterns vary across patients.

The patient described OFF time through real-world experiences such as difficulty with movement, freezing, and cognitive changes like mental fog. These symptoms can occur unpredictably or in response to stress, making them challenging to manage. They highlight how OFF periods can interfere with routine activities and create uncertainty throughout the day, reinforcing the importance of recognizing these fluctuations early and communicating them clearly to the care team.

The clinician further explains the underlying mechanisms that contribute to OFF time, focusing on both central and peripheral factors. As Parkinson’s disease progresses, the brain loses its ability to store and regulate dopamine, reducing buffering capacity and leading to more noticeable fluctuations. At the same time, issues such as delayed gastric emptying, variable medication absorption, and dietary interactions can affect how well medications work. Together, these factors contribute to the complexity of managing Parkinson’s disease and underscore the need for individualized treatment strategies.

In the next episode, ‘Managing OFF Time in Parkinson’s Disease’, panelists will examine how combination treatment strategies help address motor fluctuations and dyskinesia. The discussion highlights real-world experiences with injectable therapies and extended-release medications to improve symptom control.


Latest CME